ALA 5%

DRUG2 trials

Sponsors

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Conditions

Acne Vulgaris

Phase 1

A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris

CompletedNCT04018885

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.Acne Vulgaris

Start: 2019-07-11End: 2020-01-20Updated: 2020-06-02

Pharmacokinetics and Safety of ALA in Acne Vulgaris

CompletedNCT04044898

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.Acne Vulgaris

Start: 2021-01-12End: 2021-12-06Updated: 2022-03-17